SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-023426
Filing Date
2024-02-05
Accepted
2024-02-05 07:00:31
Documents
16
Period of Report
2024-02-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d80880d8k.htm   iXBRL 8-K 55566
2 EX-2.1 d80880dex21.htm EX-2.1 572448
3 EX-99.1 d80880dex991.htm EX-99.1 28441
  Complete submission text file 0001193125-24-023426.txt   931150

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ctlt-20240205.xsd EX-101.SCH 2840
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctlt-20240205_lab.xml EX-101.LAB 17234
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctlt-20240205_pre.xml EX-101.PRE 10805
17 EXTRACTED XBRL INSTANCE DOCUMENT d80880d8k_htm.xml XML 3488
Mailing Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873
Business Address 14 SCHOOLHOUSE ROAD SOMERSET NJ 08873 (732) 537-6200
Catalent, Inc. (Filer) CIK: 0001596783 (see all company filings)

IRS No.: 208737688 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36587 | Film No.: 24593921
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)